CA2022654C - Skin whitening cosmetics - Google Patents
Skin whitening cosmetics Download PDFInfo
- Publication number
- CA2022654C CA2022654C CA002022654A CA2022654A CA2022654C CA 2022654 C CA2022654 C CA 2022654C CA 002022654 A CA002022654 A CA 002022654A CA 2022654 A CA2022654 A CA 2022654A CA 2022654 C CA2022654 C CA 2022654C
- Authority
- CA
- Canada
- Prior art keywords
- cosmetic
- fatty acid
- acid
- skin whitening
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 230000002087 whitening effect Effects 0.000 title claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 35
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 20
- 229930195729 fatty acid Natural products 0.000 claims abstract description 20
- 239000000194 fatty acid Substances 0.000 claims abstract description 20
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 229920002545 silicone oil Polymers 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 150000002148 esters Chemical class 0.000 claims abstract description 11
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 16
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 14
- 208000012641 Pigmentation disease Diseases 0.000 description 14
- 239000004205 dimethyl polysiloxane Substances 0.000 description 14
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 14
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 14
- 230000019612 pigmentation Effects 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- 235000020778 linoleic acid Nutrition 0.000 description 13
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 12
- -1 and in some cases Chemical class 0.000 description 10
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- BKMUDUXPSVRLFZ-UHFFFAOYSA-N 2-methyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical compound C[SiH]1O[SiH2]O[SiH2]O[SiH2]O[SiH2]O1 BKMUDUXPSVRLFZ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N gallic acid propyl ester Natural products CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000024181 negative regulation of developmental pigmentation Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RSNQKPMXXVDJFG-UHFFFAOYSA-N tetrasiloxane Chemical compound [SiH3]O[SiH2]O[SiH2]O[SiH3] RSNQKPMXXVDJFG-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
A skin whitening cosmetic is disclosed, which comprises (a) at least one compound selected from the group consisting of a free fatty acid having from 18 to 22 carbon atoms and containing at least two unsaturated bonds per molecule, a salt of the fatty acid, and an ester of the fatty acid with a monohydric or dihydric alcohol, and (b) at least one silicone oil selected from the group consisting of compounds represented by formulae (I), (II), and (III):
(see formula I) wherein n1 represents an integer of from 4 to 6, (see formula II) wherein n2 represents an integer of from 1 to 400, (see formula III) wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from 1 to 400.
(see formula I) wherein n1 represents an integer of from 4 to 6, (see formula II) wherein n2 represents an integer of from 1 to 400, (see formula III) wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from 1 to 400.
Description
~~~'~~~e SKIN WHITENING COSMETICS
FIELD OF THE INVENTION
This invention relates to a skin whitening cosmetic containing a specific fatty acid or a derivative thereof which is effective to eliminate or prevent skin browning or pigmentation in the skin, e.g., spots or freckles, due to ultraviolet light, BACKGROUND OF THE INVENTION
Known cosmetics for giving fairness to the facial skin include compositions containing ascorbic acid or a derivative thereof or a tyrosinase inhibitor, e.g., a placenta extract and kojic acid or a derivative thereof.
Although these conventional skin whitening cosmetics exhibit inhibitory activity against melanin production when tested in vitro using tissue cultures, they have not succeeded in obtaining sufficient effects on elimination of pigmentation when actually applied to the skin.
As a result of extensive researches on various components for their skin whitening effects, the inventors have previously discovered that incorporation of a specific fatty acid or a salt or an ester thereof into cosmetics brings about excellent skin whitening effects and filed an application for patent. It turned out, however, that such a fatty acid or a derivative thereof is still insufficient in skin whitening effect upon actual use when combined with fats and oils generally employed in conventional cosmetics.
SUMMARY OF THE INVENTION
Accordingly, an object of this invention is to provide a cosmetic containing a specific fatty acid or a salt or an ester thereof in which the skin whitening effects of the fatty acid or a salt or an ester thereof can be fully manifested.
Other objects and effects of the present invention will be apparent from the following description.
The present inventors have conducted extensive investig~itions and, as a result, found that a combination of a specific fatty acid, a salt thereof or an ester thereof with a mono- or dihydric alcohol, and a silicone oil unexpectedly produces excellent effects on elimination or prevention of pigmentation in the skin, and thus reached the present invention.
That is, the present invention relates to a skin whitening cosmetic comprising (a) at least one compound selected from the group consisting of a free fatty acid having from 18 to 22 carbon atoms and containing at least two unsaturated bonds per molecule, a salt of said fatty acid, and an ester of said fatty acid with a monohydric or dihydric alcohol, and (b) at least one silicone oil selected from the ~~~2~'r~j group consisting of compounds represented by formulae (I), (II), and (III):
(I) wherein nd represents an integer of from 4 to 6.
i Hs i Hs i Hs CH3 Si -~%- Si Si-CH3 ( II ) CH3 CH3 n2 CH3 wherein n2 represents an integer of from 1 to 400.
CH3 Si Si Si Si~H3 ( I II ) CH3 CH3 n3 / I n4 CH3 wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from l, to 400.
The present invention further relates to a skin whitening cosmetic comprising (c) ethanol in addition to the above-described components (a) and (b).
_ 3 DETAILED DESCRIPTION OF THE INVENTION
Fatty acids having from 18 to 22 carbon atoms and at least two unsaturated bonds per molecule, e.g., linoleic acid and y-linolenic acid, which can be used in the present invention are contained in vegetable and animal fats and oils. Rarely are these fatty acids present in a free form, and most of them are present in the form of triglyceride.
Such tr:i.glycerides reveal no such significant effects on inhibition of pigmentation in animal experiments as are observed with free fatty acids or alkyl esters thereof.
Neither do saturated fatty acids, e.g., palmitic acid and stearic acid, and in some cases, saturated fatty acids rather accelerate melamine production. Considering that these saturated fatty acids are present in vegetable and animal fats and oils in large quantities, it is preferable to use a purified unsaturated fatty acid in the preparation of the cosmetic of the present invention.
Examples of the free unsaturated fatty acids containing from 18 to 22 carbon atoms and at least two unsaturated bonds per molecule include linoleic acid, linoelaidic acid, oc-l5.nolenic acid, y-linolenic acid, dihomo-y-linolenic acid, arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. These fatty acids may be used either individually or in combination of two or more thereof.
~~~2~~~
These free unsaturated fatty acids are obtained by saponification of natural fats and oils. Examples of the natural fats and oils include vegetable fats and oils, e.g., linseed oil, safflower oil, sunflower oil, soybean oil, rape oil, corn oil, sesame oil,, and gape seed oil; and marine animal oils, e.g., cuttlefish oil, sardine oil, saury oily and cod liver oil.
Examples of salts of these free fatty acids which can be used in the present invention include metal salts, e.g., a sodium salt and a potassium salt; amino acid salts, e.g., an arginine salt and a lysine salt; and amine salts, e.g., a triethanolamine salt and a monoethanolamine salt.
Examples of alkyl esters of the fatty acids which can be used in the present invention include esters with monohydric alcohols, e.g., methanol, ethanol, and isopropyl alcohol; and dihydric alcohols, e.g., ethylene glycol, propylene glycol, and 1,3-butylene glycol.
Among the above free unsaturated fatty acids and a salt or an ester of these fatty acids, linoleic acid, a-linolenic acid, y-linolenic acid, arachidonic acid, and sodium linoleate are preferably used in the present invention. Particularly, linoleic acid and a-linolenic acid are more preferred.
The free fatty acid and a salt or an ester thereof are preferably used :in an amount of from 0.1 to 10$ by s~ ~ r weight, and preferably from 0.1 to 5~ by weight, based on the total amount of the cosmetic of the present invention. If the amount is less than 0.1~ by weight, no inhibitory activity on pigmentation tends to be exerted. If it exceeds 10~ by weight, skin irritation may be caused.
The silicone oil which is used in combination with the above-described component (a) is selected from the compounds represented by the above-described formulae (I), (II), and (III).
Examples of the silicone oil of formula (I) include KF~94 and KF995 (products of Shin-Etsu Chemical Co., Ltd.) and SH244 and SH245 (products of Toray Silicone Co., Ltd.).
Examples of the silicone oil of formula (II) include KF96 1 cs and KF96 2 cs (products of Shin-Etsu Chemical Co., Ltd.) and SH200c/1 cs, SH200c/10 cs, SH200c/100 cs, and SH200c/500 cs (products of Toray Silicone Co., Ltd.).
Examples of the silicone oil of formula (III) include SH556 (product of Toray Silicone Co., Ltd.).
Among the above silicone oils, compounds represented by formula (I) in which nl represents an integer of from 4 to 6 and compounds represented by formula (II) in which n2 represents an integer of from 1 to 10 are preferably used in the present invention. Particularly, compounds represented by formula (I) in which nl represents an integer of from 4 to e~ S
and compounds represented by formula (II) in which nZ
represents an integer o.f from 1 to 7 are mare preferred.
The silicone oil is preferably used in an amount of 1~ by weight or more, more preferably 10~ by weight or more, and particularly preferably 50~ by weight or more, based on the total amount of the cosmetic of the present invention.
Silicone oil to be used can be arbitrarily chosen from the above-described compounds. Two or more of these silicone oils can be used in combination for the purpose of improving feel on application, solubility of fatty acids, and anti-freezing properties at low temperatures.
For example: although octamethylcyclotetrasiloxane freezes at low temperature (10°C or lower), freezing at low temperatures can be prevented by adding decamethylcyclopenta-siloxane, methylphenylsiloxane or dimethylsiloxane; although linoleic acid, a-linolenic acid and the like are not soluble in dimethylpolysiloxane, the solubilities can be improved by adding methylphenylsiloxane or octamethylcyclotetrasilxane;
and although octamethylcyclotetrasilxane and decamethylcyclo-pentasiloxane have less oleophilic feel upon use and therefore are not excellent in feel of cosmetics on application, the feel of cosmetics can be improved by adding dimethylsiloxane or methylphenylsiloxane.
For the same purpose, the cosmetic of the present invention may further contain ethanol. Ethanol is preferably - ~~~~~a~
used in an amount not more than 50.0 by weight, more preferably from 1 to ~0~ by weight, and particularly preferably from 3 to 25~ by weight, based on the total amount of the cosmetic. If the amount of ethanol exceeds 50.0 by weight, the cosmetic not only causes irritation to the skin but feels cold on application due to volatilization of ethanol, thus greatly deteriorating feel on use.
The cosmetics of the present invention can be formulated into cosmetic oils, creams, and so on according to known techniques.
If desired, the cosmetics of the present invention may further contain other components generally employed in cosmetics as long as the effects of the present invention are not impaired.
The conventional compositions and its production process as well as the conventional components added therefor of the cosmetic compositions axe described, e.g., in Keshohin-Gaku (Cosmetic Science), edited by T. Ikeda, published on May 20, 1979 by Nanzando, Japan, which is incorporated herein by reference, but the present invention is not construed as being limited thereto.
Furthermore, if desired, the cosmetics of the present invention can contain various conventional additives, such as melanin production inhibitors (whitening agents) (e. g., vitamin C and placenta extract), anti-inflammatory agents, g _ and antioxidants, as long as the effects of the present invention are not impaired.
Examples of the conventional additives and their addition amounts are shown in Table 1 below but they are not limited thereto. The addition amounts are shown in terms of percent by weight (except Vitamin A) based on the total amount of the cosmetic compositions.
_ g _ n, a'' :- , ~.~~~~~:'a-_gls:
Additives Addition amount by weight) Whitenin~aqent Placenta extract 0.1 to3 Kojic acid 0.1 to3 Photosensitive 0.0001 to0.002 element No. 201 Plant extract 0.01 to1 Vitamin A 500 IU to 2,500 IU
Anti-inflammatory agent Dipotassium 0.01 to0.2 grycyrrhizic acid Stearil 0.01 to0.2 grycyrrethinate Allantoin 0.01 to0.2 s-Aminocaproic acid 0.01 to0.1 Methyl salicyJ.ate 0.01 to0.1 Antioxidant Dibutylhydroxytoluene 0.01 to 1 Butylhydroxyanisole 0.01 to 1 Propyl gallate 0.01 to 0.2 Tocopherol 0.01 to 1 Erythorbic acid 0.0001 to 0.05 The cosmetics according to the present invention can be applied to the skin by conventional manners. For example, a.
_ 10 _ lotion containing 1 wt~ of the compound of the present invention can be applied by hands 1 to several times per day;
one or two drops of a cosmetic oil containing 3 wt~ of the compounds can be applied to the portion at which pigmentation occurs by fingers 1 to 3 times per day; a cream containing 5 wt~ of the compound can be applied by hands 1 to several times per day; an emulsion containing 2 wt~ of the compound can be applied by hands 1 to 3 times per day; and a pack can be used in such a manner that 5 to 10 g of the pack is applied to the facial skin other than eyes and nose, and it allows to stand for about 30 minutes followed by being removed 1 to 2 times per week.
Skin whitening effects according to the present invention was tested as follows.
Test Method:
Ultraviolet light (UVB intensity: 1 J/cm2) was 4 times (twice per week) irradiated on the shaved back of English brown guinea pigs. One week after from the irradiation, a pigmentation was formed.
On 6 cm2 (2 cm x 3 cm) of the back of the guinea pigs having the pigmentation, 0.05 ml of a solution of a linoleic acid in each of bases shown in Table 1 below was 20 times (once per day) applied.
,J Li :w The degree of pigmentation was observed with eyes and evaluated as follows taking that of the area where no test compound was applied as a standard (0).
0: No reduction in pigmentation was observed.
-1: Slight reduction in pigmentation was observed.
-2: Medium reduction in pigmentation was observed.
FIELD OF THE INVENTION
This invention relates to a skin whitening cosmetic containing a specific fatty acid or a derivative thereof which is effective to eliminate or prevent skin browning or pigmentation in the skin, e.g., spots or freckles, due to ultraviolet light, BACKGROUND OF THE INVENTION
Known cosmetics for giving fairness to the facial skin include compositions containing ascorbic acid or a derivative thereof or a tyrosinase inhibitor, e.g., a placenta extract and kojic acid or a derivative thereof.
Although these conventional skin whitening cosmetics exhibit inhibitory activity against melanin production when tested in vitro using tissue cultures, they have not succeeded in obtaining sufficient effects on elimination of pigmentation when actually applied to the skin.
As a result of extensive researches on various components for their skin whitening effects, the inventors have previously discovered that incorporation of a specific fatty acid or a salt or an ester thereof into cosmetics brings about excellent skin whitening effects and filed an application for patent. It turned out, however, that such a fatty acid or a derivative thereof is still insufficient in skin whitening effect upon actual use when combined with fats and oils generally employed in conventional cosmetics.
SUMMARY OF THE INVENTION
Accordingly, an object of this invention is to provide a cosmetic containing a specific fatty acid or a salt or an ester thereof in which the skin whitening effects of the fatty acid or a salt or an ester thereof can be fully manifested.
Other objects and effects of the present invention will be apparent from the following description.
The present inventors have conducted extensive investig~itions and, as a result, found that a combination of a specific fatty acid, a salt thereof or an ester thereof with a mono- or dihydric alcohol, and a silicone oil unexpectedly produces excellent effects on elimination or prevention of pigmentation in the skin, and thus reached the present invention.
That is, the present invention relates to a skin whitening cosmetic comprising (a) at least one compound selected from the group consisting of a free fatty acid having from 18 to 22 carbon atoms and containing at least two unsaturated bonds per molecule, a salt of said fatty acid, and an ester of said fatty acid with a monohydric or dihydric alcohol, and (b) at least one silicone oil selected from the ~~~2~'r~j group consisting of compounds represented by formulae (I), (II), and (III):
(I) wherein nd represents an integer of from 4 to 6.
i Hs i Hs i Hs CH3 Si -~%- Si Si-CH3 ( II ) CH3 CH3 n2 CH3 wherein n2 represents an integer of from 1 to 400.
CH3 Si Si Si Si~H3 ( I II ) CH3 CH3 n3 / I n4 CH3 wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from l, to 400.
The present invention further relates to a skin whitening cosmetic comprising (c) ethanol in addition to the above-described components (a) and (b).
_ 3 DETAILED DESCRIPTION OF THE INVENTION
Fatty acids having from 18 to 22 carbon atoms and at least two unsaturated bonds per molecule, e.g., linoleic acid and y-linolenic acid, which can be used in the present invention are contained in vegetable and animal fats and oils. Rarely are these fatty acids present in a free form, and most of them are present in the form of triglyceride.
Such tr:i.glycerides reveal no such significant effects on inhibition of pigmentation in animal experiments as are observed with free fatty acids or alkyl esters thereof.
Neither do saturated fatty acids, e.g., palmitic acid and stearic acid, and in some cases, saturated fatty acids rather accelerate melamine production. Considering that these saturated fatty acids are present in vegetable and animal fats and oils in large quantities, it is preferable to use a purified unsaturated fatty acid in the preparation of the cosmetic of the present invention.
Examples of the free unsaturated fatty acids containing from 18 to 22 carbon atoms and at least two unsaturated bonds per molecule include linoleic acid, linoelaidic acid, oc-l5.nolenic acid, y-linolenic acid, dihomo-y-linolenic acid, arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. These fatty acids may be used either individually or in combination of two or more thereof.
~~~2~~~
These free unsaturated fatty acids are obtained by saponification of natural fats and oils. Examples of the natural fats and oils include vegetable fats and oils, e.g., linseed oil, safflower oil, sunflower oil, soybean oil, rape oil, corn oil, sesame oil,, and gape seed oil; and marine animal oils, e.g., cuttlefish oil, sardine oil, saury oily and cod liver oil.
Examples of salts of these free fatty acids which can be used in the present invention include metal salts, e.g., a sodium salt and a potassium salt; amino acid salts, e.g., an arginine salt and a lysine salt; and amine salts, e.g., a triethanolamine salt and a monoethanolamine salt.
Examples of alkyl esters of the fatty acids which can be used in the present invention include esters with monohydric alcohols, e.g., methanol, ethanol, and isopropyl alcohol; and dihydric alcohols, e.g., ethylene glycol, propylene glycol, and 1,3-butylene glycol.
Among the above free unsaturated fatty acids and a salt or an ester of these fatty acids, linoleic acid, a-linolenic acid, y-linolenic acid, arachidonic acid, and sodium linoleate are preferably used in the present invention. Particularly, linoleic acid and a-linolenic acid are more preferred.
The free fatty acid and a salt or an ester thereof are preferably used :in an amount of from 0.1 to 10$ by s~ ~ r weight, and preferably from 0.1 to 5~ by weight, based on the total amount of the cosmetic of the present invention. If the amount is less than 0.1~ by weight, no inhibitory activity on pigmentation tends to be exerted. If it exceeds 10~ by weight, skin irritation may be caused.
The silicone oil which is used in combination with the above-described component (a) is selected from the compounds represented by the above-described formulae (I), (II), and (III).
Examples of the silicone oil of formula (I) include KF~94 and KF995 (products of Shin-Etsu Chemical Co., Ltd.) and SH244 and SH245 (products of Toray Silicone Co., Ltd.).
Examples of the silicone oil of formula (II) include KF96 1 cs and KF96 2 cs (products of Shin-Etsu Chemical Co., Ltd.) and SH200c/1 cs, SH200c/10 cs, SH200c/100 cs, and SH200c/500 cs (products of Toray Silicone Co., Ltd.).
Examples of the silicone oil of formula (III) include SH556 (product of Toray Silicone Co., Ltd.).
Among the above silicone oils, compounds represented by formula (I) in which nl represents an integer of from 4 to 6 and compounds represented by formula (II) in which n2 represents an integer of from 1 to 10 are preferably used in the present invention. Particularly, compounds represented by formula (I) in which nl represents an integer of from 4 to e~ S
and compounds represented by formula (II) in which nZ
represents an integer o.f from 1 to 7 are mare preferred.
The silicone oil is preferably used in an amount of 1~ by weight or more, more preferably 10~ by weight or more, and particularly preferably 50~ by weight or more, based on the total amount of the cosmetic of the present invention.
Silicone oil to be used can be arbitrarily chosen from the above-described compounds. Two or more of these silicone oils can be used in combination for the purpose of improving feel on application, solubility of fatty acids, and anti-freezing properties at low temperatures.
For example: although octamethylcyclotetrasiloxane freezes at low temperature (10°C or lower), freezing at low temperatures can be prevented by adding decamethylcyclopenta-siloxane, methylphenylsiloxane or dimethylsiloxane; although linoleic acid, a-linolenic acid and the like are not soluble in dimethylpolysiloxane, the solubilities can be improved by adding methylphenylsiloxane or octamethylcyclotetrasilxane;
and although octamethylcyclotetrasilxane and decamethylcyclo-pentasiloxane have less oleophilic feel upon use and therefore are not excellent in feel of cosmetics on application, the feel of cosmetics can be improved by adding dimethylsiloxane or methylphenylsiloxane.
For the same purpose, the cosmetic of the present invention may further contain ethanol. Ethanol is preferably - ~~~~~a~
used in an amount not more than 50.0 by weight, more preferably from 1 to ~0~ by weight, and particularly preferably from 3 to 25~ by weight, based on the total amount of the cosmetic. If the amount of ethanol exceeds 50.0 by weight, the cosmetic not only causes irritation to the skin but feels cold on application due to volatilization of ethanol, thus greatly deteriorating feel on use.
The cosmetics of the present invention can be formulated into cosmetic oils, creams, and so on according to known techniques.
If desired, the cosmetics of the present invention may further contain other components generally employed in cosmetics as long as the effects of the present invention are not impaired.
The conventional compositions and its production process as well as the conventional components added therefor of the cosmetic compositions axe described, e.g., in Keshohin-Gaku (Cosmetic Science), edited by T. Ikeda, published on May 20, 1979 by Nanzando, Japan, which is incorporated herein by reference, but the present invention is not construed as being limited thereto.
Furthermore, if desired, the cosmetics of the present invention can contain various conventional additives, such as melanin production inhibitors (whitening agents) (e. g., vitamin C and placenta extract), anti-inflammatory agents, g _ and antioxidants, as long as the effects of the present invention are not impaired.
Examples of the conventional additives and their addition amounts are shown in Table 1 below but they are not limited thereto. The addition amounts are shown in terms of percent by weight (except Vitamin A) based on the total amount of the cosmetic compositions.
_ g _ n, a'' :- , ~.~~~~~:'a-_gls:
Additives Addition amount by weight) Whitenin~aqent Placenta extract 0.1 to3 Kojic acid 0.1 to3 Photosensitive 0.0001 to0.002 element No. 201 Plant extract 0.01 to1 Vitamin A 500 IU to 2,500 IU
Anti-inflammatory agent Dipotassium 0.01 to0.2 grycyrrhizic acid Stearil 0.01 to0.2 grycyrrethinate Allantoin 0.01 to0.2 s-Aminocaproic acid 0.01 to0.1 Methyl salicyJ.ate 0.01 to0.1 Antioxidant Dibutylhydroxytoluene 0.01 to 1 Butylhydroxyanisole 0.01 to 1 Propyl gallate 0.01 to 0.2 Tocopherol 0.01 to 1 Erythorbic acid 0.0001 to 0.05 The cosmetics according to the present invention can be applied to the skin by conventional manners. For example, a.
_ 10 _ lotion containing 1 wt~ of the compound of the present invention can be applied by hands 1 to several times per day;
one or two drops of a cosmetic oil containing 3 wt~ of the compounds can be applied to the portion at which pigmentation occurs by fingers 1 to 3 times per day; a cream containing 5 wt~ of the compound can be applied by hands 1 to several times per day; an emulsion containing 2 wt~ of the compound can be applied by hands 1 to 3 times per day; and a pack can be used in such a manner that 5 to 10 g of the pack is applied to the facial skin other than eyes and nose, and it allows to stand for about 30 minutes followed by being removed 1 to 2 times per week.
Skin whitening effects according to the present invention was tested as follows.
Test Method:
Ultraviolet light (UVB intensity: 1 J/cm2) was 4 times (twice per week) irradiated on the shaved back of English brown guinea pigs. One week after from the irradiation, a pigmentation was formed.
On 6 cm2 (2 cm x 3 cm) of the back of the guinea pigs having the pigmentation, 0.05 ml of a solution of a linoleic acid in each of bases shown in Table 1 below was 20 times (once per day) applied.
,J Li :w The degree of pigmentation was observed with eyes and evaluated as follows taking that of the area where no test compound was applied as a standard (0).
0: No reduction in pigmentation was observed.
-1: Slight reduction in pigmentation was observed.
-2: Medium reduction in pigmentation was observed.
-3: Considerable reduction in pigmentation was observed.
The results of the evaluation are shown in Table 2 below.
Conc, of Linoleic Base Acid Evaluation (wt~) White petrolatum 5.0 0 Liquid paraffin 5.0 -1 " 0.1 0 Squalane 5.0 -1 Isocetyl stearate 5.0 -1 Octamethylcyclotetrasiloxane*1 0.1 -2 " 5.0 -3 Decamethylcyclopentasiloxane*Z 0.1 -2 " 5.0 -3 Dimethylpolysiloxane (500 0.1 -2 cs) " (100 cs) 0.1 -2 " (10 cs) 0.1 -2 " (10 cs) 5.0 -3 ' (1 cs) 0.1 -2 " (1 cs) 5.0 -3 Methylphenylpolysiloxane 0.1 -2 " 5.0 -3 Dimethylpolysiloxane (500 5.0 -3 cs)/methyl-phenylpolysiloxane (1/3 by weight) Dimethylpolysiloxane (100/deca- 5.0 -3 cs) methylcyclopentasiloxane (1/1 by weight) Octamethylcyclotetrasiloxane/dimethyl- 0.1 -2 polysiloxane (500 as) (8/12 by weight) Note: *1 Formula (I)~(n=4) *2 Formula (I) (n=5) As is apparent from the results in Table 2, significant reduction of pigmentation can be obtained when linoleic acid is combined with a silicone oil or a mixture thereof as a ?case. It is also seen that the skin whitening effect increases with an increase in concentration of linoleic acid.
Satisfactory effects can be obtained with linoleic acid of from 0.1 to 10~k by weight, and preferably from 0.1 to 5~ by weight. It was noted, however, that linoleic acid when used at high concentrations is not dissolved in a silicone oil base depending on the kind. of the silicone oil.
Solubility of linoleic acid in a silicone oil or a mixed silicone oil is shown in Tables 3 and 4.
Conc. of Linoleic Acid Kind of Silicone Oil 1$ by wt. 5$ by wt.
Octamethylcyclotetrasiloxane soluble soluble Decamethylcyclopentasiloxane " "
Dimethylpolysiloxane (500 cs) " insoluble " (100 cs) " "
" (10 cs) " soluble " (1 cs) ° "
Methylphenylpolysiloxane ~ " "
to ~, ,~ T3 x o ~ p w ..
a ~ - _ _ _ , x ~ m N
.~e r-I p rl N ri N
U
.~, ~ ~ f~'~ ~', N
N
_ _ O ~ O O C~ O i11 ' wl ~ G' ..~Li ~ , U7 r1 U7 .~
x O
U N 'CfO T1 -t rl I
,~ N ri N
O .~
~~i ~
~ N ~r ''I ' N '"I - N
~ A
A P
a .~ cn ..I u~
rtf O
U
ri ~d p O
O
H N ~ x r~l ~ - r~1 ~ -rp-I
O p O p O
'1 r t t ~i n n o II
a ~~ ~ rol a~ ~ m O
U -~ U1 U 'Jy ~ ~
N
O U
+~ O
Lta ~ ~-i rl M r-i r1 M
j \
~ ~ \ \ \ \ \ \
R~, M r-Irl M v-i rl ~
~
U U
~o r1 ri lrt r~
.-~
.,.I p .... O
O fli Ra ~
r1 Q1 ,-I
O
~ ~b gym . .
o .~x .~x U N O N O
w-1 .~, ~ r-!
~-~1 rl .-I .-i ml .~
.~ (~ !n (.~
In --,~ v "~ w~
i I O
r-I .--I I
b 5C SC O O O O O O , ,. _ N
'Jy 1 +~ ~ ~ U DC >C O O O O O O
o ~ O
o a ~ Dy c d U
j . DC DC O O O O O O
+~ ~-1 o ~ f~
~
--I
r r l i O
rl to rl q i O Si y ~ U
The results of the evaluation are shown in Table 2 below.
Conc, of Linoleic Base Acid Evaluation (wt~) White petrolatum 5.0 0 Liquid paraffin 5.0 -1 " 0.1 0 Squalane 5.0 -1 Isocetyl stearate 5.0 -1 Octamethylcyclotetrasiloxane*1 0.1 -2 " 5.0 -3 Decamethylcyclopentasiloxane*Z 0.1 -2 " 5.0 -3 Dimethylpolysiloxane (500 0.1 -2 cs) " (100 cs) 0.1 -2 " (10 cs) 0.1 -2 " (10 cs) 5.0 -3 ' (1 cs) 0.1 -2 " (1 cs) 5.0 -3 Methylphenylpolysiloxane 0.1 -2 " 5.0 -3 Dimethylpolysiloxane (500 5.0 -3 cs)/methyl-phenylpolysiloxane (1/3 by weight) Dimethylpolysiloxane (100/deca- 5.0 -3 cs) methylcyclopentasiloxane (1/1 by weight) Octamethylcyclotetrasiloxane/dimethyl- 0.1 -2 polysiloxane (500 as) (8/12 by weight) Note: *1 Formula (I)~(n=4) *2 Formula (I) (n=5) As is apparent from the results in Table 2, significant reduction of pigmentation can be obtained when linoleic acid is combined with a silicone oil or a mixture thereof as a ?case. It is also seen that the skin whitening effect increases with an increase in concentration of linoleic acid.
Satisfactory effects can be obtained with linoleic acid of from 0.1 to 10~k by weight, and preferably from 0.1 to 5~ by weight. It was noted, however, that linoleic acid when used at high concentrations is not dissolved in a silicone oil base depending on the kind. of the silicone oil.
Solubility of linoleic acid in a silicone oil or a mixed silicone oil is shown in Tables 3 and 4.
Conc. of Linoleic Acid Kind of Silicone Oil 1$ by wt. 5$ by wt.
Octamethylcyclotetrasiloxane soluble soluble Decamethylcyclopentasiloxane " "
Dimethylpolysiloxane (500 cs) " insoluble " (100 cs) " "
" (10 cs) " soluble " (1 cs) ° "
Methylphenylpolysiloxane ~ " "
to ~, ,~ T3 x o ~ p w ..
a ~ - _ _ _ , x ~ m N
.~e r-I p rl N ri N
U
.~, ~ ~ f~'~ ~', N
N
_ _ O ~ O O C~ O i11 ' wl ~ G' ..~Li ~ , U7 r1 U7 .~
x O
U N 'CfO T1 -t rl I
,~ N ri N
O .~
~~i ~
~ N ~r ''I ' N '"I - N
~ A
A P
a .~ cn ..I u~
rtf O
U
ri ~d p O
O
H N ~ x r~l ~ - r~1 ~ -rp-I
O p O p O
'1 r t t ~i n n o II
a ~~ ~ rol a~ ~ m O
U -~ U1 U 'Jy ~ ~
N
O U
+~ O
Lta ~ ~-i rl M r-i r1 M
j \
~ ~ \ \ \ \ \ \
R~, M r-Irl M v-i rl ~
~
U U
~o r1 ri lrt r~
.-~
.,.I p .... O
O fli Ra ~
r1 Q1 ,-I
O
~ ~b gym . .
o .~x .~x U N O N O
w-1 .~, ~ r-!
~-~1 rl .-I .-i ml .~
.~ (~ !n (.~
In --,~ v "~ w~
i I O
r-I .--I I
b 5C SC O O O O O O , ,. _ N
'Jy 1 +~ ~ ~ U DC >C O O O O O O
o ~ O
o a ~ Dy c d U
j . DC DC O O O O O O
+~ ~-1 o ~ f~
~
--I
r r l i O
rl to rl q i O Si y ~ U
, DC DC ?C?C O O O O
.
O O
W ~ ~
o ~
~ Ca 't3 a a~ w o , O ~~~~
U
O V O o ~ >C ~'"~' p O O O
N O
~
~
r-Iml In ,~
,, N
W
i i U
cd ~ N
'-' o ~ ~C >C O O O O O O
.,.i d ~N
.N O o A .4 M t0 OD~ N d' l0 07 I
\ tT \ \ \ \ r1 ri .-1.--t ~
U ~ t~ c~ N o \ \
td ~ Ri -1 .~ .-1~,~,CO tD d' N
U
U
.4 .-I 1 O ~ rtJ
tT ~
.~ f-a N ~
.-i N +~ ~
!~ 'i p O N rt t~7 ..
U ~ O O ' _ _ _ _ _ _ ~ p .-1+~ .-I
.-i ~-i ri ~-IU U .-I
W O
.-iO ,'~y UJ ~
u~ U
--TABLE s Octamethylcyclo- Linoleic tetrasiloxane Ethanol Acid Evaluation by wt.) (~ by wt.) (~ by wt.) Note: 0: Not freese at 0°C
X: Freeze at 0°C
As is apparent from the results in Table 3, linoleic acid of high concentration lacks solubility in dimethylpolysiloxane having a viscosity of 100 cs or more. In the case, solubility of linoleic acid can be increased by adding an adequate amount of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, methylphenylpolysiloxane, etc. as shown in Table 4.
Tables 5 and 6 shows low temperature stability of octa-methylcyclotetrasiloxane. Although octamethylcyclotetra-siloxan~ freezes at low temperatures because of its high coagulation point, freezing can be prevented by a combined use of an adequate amount of decamethylcyclopentasiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, or ethanol.
17 _ The present invention is now illustrated in greater detail by way of the following Examples, but it should be understood that the present invention is not deemed to be limited thereto. All the percents are by weight unless otherwise indicated.
Cosmetic Oil:
Linoleic acid 1.5~
Octamethylcyclotetrasiloxane 78.3$
Decamethylcyclopentasiloxane 20.0 Dibutylhydroxytoluene . 0.1~
Tocopherol 0.1~
Total: 100.0 Cosmetic Oil:
Eicosapentaenoic acid 2.0~
Dimethylpolysiloxane (2 cs) 89.8 Retinol 0.1~
Ethyl p-dimethylaminobenzoate 2.0~
Propyl p-hydroxybenzoate 0.1~
Methylphenylpolysiloxane 6.0~
Total: loo. o$
Cosmetic Oil:
y-Linolenic acid 1.5~
Octamethylcyclotetrasiloxane 79.6 Dimethylpolysiloxane (2 cs) 17.8 Soybean phospholipid 0.1~
Cinoxate 1.0~
Total: 100.0 Cosmetic Oil:
Ethyl linoleate 1.5~
Octamethylcyclotetrasiloxane 60.0 Decamethylcyclopentasiloxane 20.0 Dimethylpolysiloxane (100 cs) 18.3 Butylhydroxyanisole 0.2~
Total: 100.0 Cosmetic Oil:
y-Linolenic acid 2.0~
Octamethylcyclotetrasiloxane 85.0$
Dimethylpolysiloxane (50 cs) 12.8 Tocopherol ~ 0.2~
Total: 100.0 19 _ _ 2~~~~i~~' Cosmetic Oil:
a-Linoleic acid 2.5~
Dimethylpolysiloxane (2 cs) 35.0$
Octamethylcyclotetrasiloxane 42.2 Ethanol 20.0 Stearyl glycyrrhetinate 0.1~
Ascorbyl stearate 0.1$
Dibutylhydroxytoluene 0.1$
Total: 100.0 In the above Examples 1 to 6, all the component were uniformly mixed and dissolved with: each other to obtain cosmetic oils.
Cream:
Linoleic acid 1.0$
Dibutylhydroxytoluene 0.05 ,Decamethylcyclopentasiloxane 15.0 Dimethylpolysiloxane (500 cs) 2.0~
Monoglyceryl linoleate 2.0$
Monoglyceryl oleate 2.0~
Olive oil ' 2.0~
Methyl p-hydroxybenzoate 0.1~
~~~~~r Citric acid 0.05%
Concentrated glycerin 15.0%
Dimethylpolysiloxane/polyethylene glycol 5.0%
copolymer ' Purified water 55.8%
Total: 100.0%
In the above Examples 1 to 6, all the component were uniformly mixed and dissolved with each other to obtain a cream.
The cosmetics according to the present invention, when applied to the skin, eliminate or prevent browning or pigmentation of the skin due to ultraviolet light and exhibit excellent skin whitening effects.
While the invention has been described in detail with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made 'therein without departing from the spirit and scope thereof.
.
O O
W ~ ~
o ~
~ Ca 't3 a a~ w o , O ~~~~
U
O V O o ~ >C ~'"~' p O O O
N O
~
~
r-Iml In ,~
,, N
W
i i U
cd ~ N
'-' o ~ ~C >C O O O O O O
.,.i d ~N
.N O o A .4 M t0 OD~ N d' l0 07 I
\ tT \ \ \ \ r1 ri .-1.--t ~
U ~ t~ c~ N o \ \
td ~ Ri -1 .~ .-1~,~,CO tD d' N
U
U
.4 .-I 1 O ~ rtJ
tT ~
.~ f-a N ~
.-i N +~ ~
!~ 'i p O N rt t~7 ..
U ~ O O ' _ _ _ _ _ _ ~ p .-1+~ .-I
.-i ~-i ri ~-IU U .-I
W O
.-iO ,'~y UJ ~
u~ U
--TABLE s Octamethylcyclo- Linoleic tetrasiloxane Ethanol Acid Evaluation by wt.) (~ by wt.) (~ by wt.) Note: 0: Not freese at 0°C
X: Freeze at 0°C
As is apparent from the results in Table 3, linoleic acid of high concentration lacks solubility in dimethylpolysiloxane having a viscosity of 100 cs or more. In the case, solubility of linoleic acid can be increased by adding an adequate amount of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, methylphenylpolysiloxane, etc. as shown in Table 4.
Tables 5 and 6 shows low temperature stability of octa-methylcyclotetrasiloxane. Although octamethylcyclotetra-siloxan~ freezes at low temperatures because of its high coagulation point, freezing can be prevented by a combined use of an adequate amount of decamethylcyclopentasiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, or ethanol.
17 _ The present invention is now illustrated in greater detail by way of the following Examples, but it should be understood that the present invention is not deemed to be limited thereto. All the percents are by weight unless otherwise indicated.
Cosmetic Oil:
Linoleic acid 1.5~
Octamethylcyclotetrasiloxane 78.3$
Decamethylcyclopentasiloxane 20.0 Dibutylhydroxytoluene . 0.1~
Tocopherol 0.1~
Total: 100.0 Cosmetic Oil:
Eicosapentaenoic acid 2.0~
Dimethylpolysiloxane (2 cs) 89.8 Retinol 0.1~
Ethyl p-dimethylaminobenzoate 2.0~
Propyl p-hydroxybenzoate 0.1~
Methylphenylpolysiloxane 6.0~
Total: loo. o$
Cosmetic Oil:
y-Linolenic acid 1.5~
Octamethylcyclotetrasiloxane 79.6 Dimethylpolysiloxane (2 cs) 17.8 Soybean phospholipid 0.1~
Cinoxate 1.0~
Total: 100.0 Cosmetic Oil:
Ethyl linoleate 1.5~
Octamethylcyclotetrasiloxane 60.0 Decamethylcyclopentasiloxane 20.0 Dimethylpolysiloxane (100 cs) 18.3 Butylhydroxyanisole 0.2~
Total: 100.0 Cosmetic Oil:
y-Linolenic acid 2.0~
Octamethylcyclotetrasiloxane 85.0$
Dimethylpolysiloxane (50 cs) 12.8 Tocopherol ~ 0.2~
Total: 100.0 19 _ _ 2~~~~i~~' Cosmetic Oil:
a-Linoleic acid 2.5~
Dimethylpolysiloxane (2 cs) 35.0$
Octamethylcyclotetrasiloxane 42.2 Ethanol 20.0 Stearyl glycyrrhetinate 0.1~
Ascorbyl stearate 0.1$
Dibutylhydroxytoluene 0.1$
Total: 100.0 In the above Examples 1 to 6, all the component were uniformly mixed and dissolved with: each other to obtain cosmetic oils.
Cream:
Linoleic acid 1.0$
Dibutylhydroxytoluene 0.05 ,Decamethylcyclopentasiloxane 15.0 Dimethylpolysiloxane (500 cs) 2.0~
Monoglyceryl linoleate 2.0$
Monoglyceryl oleate 2.0~
Olive oil ' 2.0~
Methyl p-hydroxybenzoate 0.1~
~~~~~r Citric acid 0.05%
Concentrated glycerin 15.0%
Dimethylpolysiloxane/polyethylene glycol 5.0%
copolymer ' Purified water 55.8%
Total: 100.0%
In the above Examples 1 to 6, all the component were uniformly mixed and dissolved with each other to obtain a cream.
The cosmetics according to the present invention, when applied to the skin, eliminate or prevent browning or pigmentation of the skin due to ultraviolet light and exhibit excellent skin whitening effects.
While the invention has been described in detail with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made 'therein without departing from the spirit and scope thereof.
Claims (4)
1. A skin whitening cosmetic comprising (a) at least one compound selected from the group consisting of a free fatty acid having from 18 to 22 carbon atoms and containing at least two unsaturated bonds per molecule, a salt of said fatty acid, and an ester of said fatty acid with a monohydric or dihydric alcohol, and (b) at least one silicone oil selected from the group consisting of compounds represented by formulae (I), (II), and (III):
wherein n1 represents an integer of from 4 to 6, wherein n2 represents an integer of from 1 to 400, wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from 1 to 400.
wherein n1 represents an integer of from 4 to 6, wherein n2 represents an integer of from 1 to 400, wherein n3 and n4 each represents an integer, the sum of n3 and n4 being from 1 to 400.
2. A skin whitening cosmetic as claimed in claim 1, wherein said compound or compounds selected from the group consisting of a free fatty acid having from 18 to 22 carbon atoms and containing at least two unsaturated bonds per molecule, a salt of said fatty acid, and an ester of said fatty acid is/are present in an amount of from 0.1 to 10% by weight based on the weight of the cosmetic.
3. A skin whitening cosmetic as claimed in claim 1, wherein said cosmetic further comprises ethanol.
4. A skin whitening cosmetic as claimed in claim 3, wherein said ethanol is present in an amount not more than 50.0% by weight based on the weight of the cosmetic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002022654A CA2022654C (en) | 1989-02-07 | 1990-08-03 | Skin whitening cosmetics |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1027944A JP2608777B2 (en) | 1989-02-07 | 1989-02-07 | Whitening cosmetics |
CA002022654A CA2022654C (en) | 1989-02-07 | 1990-08-03 | Skin whitening cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2022654A1 CA2022654A1 (en) | 1992-02-04 |
CA2022654C true CA2022654C (en) | 2000-09-26 |
Family
ID=25674252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002022654A Expired - Fee Related CA2022654C (en) | 1989-02-07 | 1990-08-03 | Skin whitening cosmetics |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2022654C (en) |
-
1990
- 1990-08-03 CA CA002022654A patent/CA2022654C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2022654A1 (en) | 1992-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2614474B2 (en) | Whitening cosmetics | |
US7105570B2 (en) | Cysteine derivatives | |
US8313755B2 (en) | Clear aqueous ceramide composition | |
JPWO2007013662A1 (en) | Anti-wrinkle / improving agent | |
JPH10130128A (en) | Cosmetics | |
BRPI1002978A2 (en) | oil-in-water emulsion composition and non-therapeutic care or makeup process for keratin materials | |
JP2003176211A (en) | Oily thickened gel-like composition, emulsified composition using the same and method for preparing the emulsified composition | |
JP2608745B2 (en) | Whitening cosmetics | |
JP4425127B2 (en) | Composition for improving melasma and composition for improving dullness | |
EP0470275B1 (en) | Skin whitening cosmetics | |
JPS63284109A (en) | Beautifying cosmetic | |
CA2022654C (en) | Skin whitening cosmetics | |
JP2003137716A (en) | External preparation for skin | |
JPH11217313A (en) | Pack cosmetic | |
JP3657068B2 (en) | Anti-photoaging agent and external preparation for skin | |
KR100698356B1 (en) | Skin cosmetics | |
KR0162643B1 (en) | Skin whitening cosmetics | |
US6602513B2 (en) | Face pack | |
JPH0193520A (en) | Beautifying and whitening cosmetic | |
JP2628328B2 (en) | Whitening cosmetics | |
JP3197936B2 (en) | Cosmetics | |
JPH0648925A (en) | Grey hair preventive | |
JPH05213735A (en) | Beautifully whitening cosmetic | |
JP2000198724A (en) | Skin-beautifying preparation for external use for skin | |
JP2644353B2 (en) | Whitening cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |